In the News

Extending DAPT for more than 1 year shows benefit in diabetic patients

Extended dual antiplatelet therapy (DAPT) was associated with lower rates of death and myocardial infarction in patients with diabetes who received first-generation drug-eluting stents, but not those without diabetes, a study found.

Metformin potentially underused among patients with mild kidney disease, study finds

More patients would be eligible for metformin use if estimated glomerular filtration rate were used to define kidney disease rather than serum creatinine, a recent study concluded.

Diabetes prevalence remains high in U.S. adults

The estimated prevalence of diabetes among U.S. adults ranged between 12% and 14% in 2011-2012, according to a recent study.

MKSAP quiz: Cardiovascular risk reduction in type 2 diabetes

This month's quiz asks readers to evaluate a 48-year-old woman with a 5-year history of type 2 diabetes mellitus.

Troponin concentration may help stratify risk in those with stable ischemic heart disease and diabetes

Researchers used a high-sensitivity assay to measure cardiac troponin T concentration at baseline, then analyzed whether it was associated with a composite end point (death from cardiovascular causes, myocardial infarction, or stroke).

Warning on DPP-4 inhibitors and insulin recall

Dipeptidyl peptidase-4 (DPP-4) inhibitors may cause joint pain that can be severe and disabling, and some insulin pods may fail, the FDA recently warned.

Spotlight on insulin formulations

Two papers published in the past month compared human and analog insulins, while another looked at the advantages and disadvantages of inhaled insulin.